Table 3.
Obstetric and neonatal outcomes of pregnant women with COVID‐19 (n = 533) a
| Variables | Values |
|---|---|
| Pregnancy complications | 66 (12.4) |
| Threatened abortion | 2 (0.3) |
| Miscarriage | 12 (2.2) |
| Hiperemezis gravidarum | 2 (0.3) |
| Cholestasis of pregnancy | 5 (0.9) |
| Fetal anomaly | 3 (0.5) |
| Intrauterine fetal demise | 1 (0.2) |
| Fetal growth restriction | 5 (0.9) |
| Gestational diabetes | 3 (0.5) |
| Gestational hypertension | 4 (0.7) |
| Preterm delivery | 22 (4.1) |
| Pre‐eclampsia | 5 (0.9) |
| Placental abruption | 1 (0.2) |
| Deep vein thrombosis | 1 (0.2) |
| Delivery status | |
| Pregnancy loss | 13 (2.4) |
| Ongoing pregnancy | 389 (73.1) |
| Delivered | 131 (24.5) |
| Time interval between diagnosis and delivery (days) | 4.76 ± 2.73 (1–12) |
| Route of delivery | |
| Normal spontaneous vaginal delivery | 43 (32.9) |
| Cesarean delivery | 87 (66.4) |
| Vaginal birth after cesarean delivery | 1 (0.7) |
| Cesarean indications | |
| Previous cesarean delivery | 38 (43.6) |
| Maternal health condition | 16 (18.4) |
| Cephalopelvic disproportion | 14 (16.1) |
| Fetal distress | 12 (13.8) |
| Macrosomia | 5 (5.7) |
| Multiple pregnancy | 2 (2.3) |
| Labor anesthesia | |
| None | 43 (32.9) |
| General | 5 (3.8) |
| Regional | 82 (62.6) |
| Spontaneous labor | 90 (68.7) |
| Gestational age at delivery (weeks) | 37.39 ± 4.23 (28–42) |
| Birth weight (g) | 3100.80 ± 626.62 (900–4350) |
| Apgar 1st min | 8 (1, 6–9) |
| Apgar 5th min | 9 (1, 8–10) |
| Admission to NICU | 13 (9.9) |
| Neonatal SARS‐CoV−2 positivity | 0 (0) |
| SARS‐CoV−2 positivity in breast milk | 1 (0.2) |
Abbreviations: COVID‐19, coronavirus disease 19; IQR, interquartile range; NICU, neonatal intensive care unit; RT‐PCR, real‐time polymerase chain reaction; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; SD, standard deviation.
a
Values are given as number (percentage), mean ± SD (range), or median (IQR, range).